Resveratrol suppresses agonist-induced monocyte adhesion to cultured human endothelial cells
- 1 May 2002
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 106 (4-5) , 243-248
- https://doi.org/10.1016/s0049-3848(02)00141-x
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Resveratrol, a Polyphenolic Compound Found in Wine, Inhibits Tissue Factor Expression in Vascular CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Suppression of nitric oxide synthase and the down‐regulation of the activation of NFκB in macrophages by resveratrolBritish Journal of Pharmacology, 1999
- The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium.Journal of Clinical Investigation, 1996
- Vasorelaxing activity of resveratrol and quercetin in isolated rat aortaGeneral Pharmacology: The Vascular System, 1996
- Wines and grape juices as modulators of platelet aggregation in healthy human subjectsClinica Chimica Acta; International Journal of Clinical Chemistry, 1996
- Cell Biology of AtherosclerosisAnnual Review of Physiology, 1995
- The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1995
- Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells.Journal of Clinical Investigation, 1994
- Inhibition of human LDL oxidation by resveratrolThe Lancet, 1993
- Wine, alcohol, platelets, and the French paradox for coronary heart diseaseThe Lancet, 1992